Replies to post #3799 on Biotech Values

[rstor1]

+++I don’t buy this+++

If increasing the # of pts meant adding centers, it could explain part of the delay.

[oc1_2]

Re: 10 mg dose…2 questions
I don’t remember ambiguity working out to for better. Anyone have more safety info from in-the-field contacts? For example could side effects be more detectable in 2004 with relatively healthy patients, as opposed to in the past with seriously ill cancer patients?
Second question is about the line between infusions and multiple injections. Anyone know if 10 mg gets us within reach of multiple injections? It seems that would be a big plus.
Regards,

Dew, belated thanks for setting up this forum. The old one seems to have lost all of it’s value.

[rph_in_wi]

RE:10mg dose

I had forgotten about the 10mg dose being included in the PK study. That does lead to a more positive conclusion.

Too much political double speak has ruined my trusting mind!

Thanks,
RPh